Study for the Improvement of Long-Term Outcome Prediction in Patients in Coma After Cardiac Arrest

NCT02231060 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2018-12-12

No results posted yet for this study

Summary

The primary objective of HOPE is to improve the accuracy of outcome prediction in anoxic-ischemic encephalopathy following cardiac arrest by bringing under close scrutiny some of the existing methods used for this purpose (e.g. somato-sensory evoked potentials). HOPE is the first multicenter prospective cohort study on coma prognosis to control for the effect of a possible self-fulfilling prophecy at the ICU and to cover the acute and neurorehabilitation phases with a long-term follow-up longer than the usual three or six months.

Conditions

  • Anoxic-Ischemic Encephalopathy

Sponsors & Collaborators

  • Else Kröner Fresenius Foundation

    collaborator OTHER
  • University Hospital Augsburg

    collaborator OTHER
  • Klinikum Ingolstadt

    collaborator OTHER
  • Klinikum Rosenheim

    collaborator OTHER
  • Therapiezentrum Burgau

    collaborator OTHER
  • Schoen Clinic Bad Aibling

    collaborator OTHER
  • Schön Klinik München Schwabing

    collaborator UNKNOWN
  • Asklepios Stadtklinik Bad Tölz

    collaborator UNKNOWN
  • Technical University of Munich

    collaborator OTHER
  • Krankenhaus Barmherzige Brüder München

    collaborator UNKNOWN
  • Roteskreuzklinikum München

    collaborator UNKNOWN
  • Deutsches Herzzentrum Muenchen

    collaborator OTHER
  • Ludwig-Maximilians - University of Munich

    lead OTHER

Principal Investigators

  • Andreas Bender, MD · Ludwig-Maximilians-Universität München

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2018-12-06
Completion
2018-12-06

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02231060 on ClinicalTrials.gov